SEC Form 4 · accession 0001225208-16-027789
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Heino Lennartz
Officer — President Europe
Period of report
Aug 5, 2015
Accepted (ET)
Feb 24, 2016 · 2:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 5, 2015 | S | 4,000 | $60.51 | D | 14,935 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.